Madrigal Pharmaceuticals
The Clinical Practice Liaison plays a vital field-based role within Madrigal’s Medical Affairs team, focused on improving the standard of care for patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH). The position involves proactively engaging healthcare professionals to provide guideline-based, non-promotional disease education on the identification, diagnosis, and management of MASH. This role serves as a bridge between the medical community and internal teams, providing strategic insights to shape broader corporate understanding and direction.
Headquarters
Conshohocken, Pennsylvania, United States
Company Size
201-500 employees
Founded
2016
Delivering a Breakthrough Treatment Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need. Left untreated, MASH can lead to progressive liver scarring, cirrhosis, liver failure, liver cancer, need for transplant and premature mortality. Our goal is to halt or reverse […]
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Madrigal Pharmaceuticals.
14% below the average for this role
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
2 weeks ago